Paysign Executive Offloads Shares Under Pre-Arranged Trading Plan

Robert Strobo, the Chief Legal Officer of Paysign, Inc., executed a sale of company stock last Friday, divesting 20,000 shares for total proceeds of approximately $109,400. According to a mandatory filing with the U.S. Securities and Exchange Commission (SEC), the transactions were carried out at an average price of $5.47 per share.

This disposal was conducted pursuant to a Rule 10b5-1 trading plan originally adopted on September 10, 2025. Such plans allow corporate insiders to establish pre-scheduled transactions for selling shares they own, thereby providing a defense against potential accusations of trading on non-public information.

Following this sale, Strobo's direct holdings in Paysign decreased by 5.76%. He continues to hold 327,290 shares directly in the company. On the day of the transaction, Paysign's equity closed trading at $5.49, representing a minor decline of $0.03 from the previous session's close.

Broader Insider Trading Context

The recent filing fits into a wider pattern observed over the last twelve months. A review of SEC disclosures reveals that insider selling activity has significantly outweighed buying. During this period, open market sales by company insiders totaled roughly $15.6 million, while purchases amounted to only about $235,400. The filings do not specify individual motivations for these transactions.

Should investors sell immediately? Or is it worth buying Paysign?

Company Performance and Analyst Perspectives

Paysign's most recent quarterly update, released on November 12, presented a mixed financial picture. The company reported third-quarter earnings per share (EPS) of $0.04, meeting consensus estimates. Revenue, however, came in at $21.60 million, surpassing analyst forecasts.

Management provided full-year 2025 EPS guidance in the range of $0.120 to $0.130. Analyst opinions on the stock vary. Data from MarketBeat shows a consensus rating of "Moderate Buy" with an average price target of $8.56. Separately, a survey of four Wall Street analysts conducted over the past three months points to a stronger "Strong Buy" consensus, with an average price objective of $9.00.

From a technical analysis standpoint, the stock's 50-day moving average currently sits at $5.36, while its 200-day moving average is at $5.83.

Investors are now looking ahead to the company's fourth-quarter earnings report, which is anticipated around March 24, 2026. The insider transaction involving the CLO has been duly reported in accordance with regulatory requirements.